David T. Howton, SVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 25,000 shares at $41.00 ($1.0M) on 2017-07-20, disclosed to the SEC on 2017-07-21.
Open-market sale of $1.0M SRPT by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.00 | 5,944 | $244K | 23.8% |
| 2 | $41.00 | 19,056 | $781K | 76.2% |
| Total | $41.00 avg | 25,000 | $1.0M | 100% |
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |